179 related articles for article (PubMed ID: 18258853)
21. Ace2 receives helping hand for cell-cycle transcription.
Rodríguez-López M; Bähler J
Cell Cycle; 2015; 14(21):3351-2. PubMed ID: 26399486
[No Abstract] [Full Text] [Related]
22. ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function.
Xia H; Suda S; Bindom S; Feng Y; Gurley SB; Seth D; Navar LG; Lazartigues E
PLoS One; 2011; 6(7):e22682. PubMed ID: 21818366
[TBL] [Abstract][Full Text] [Related]
23. Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension.
Feng Y; Xia H; Cai Y; Halabi CM; Becker LK; Santos RA; Speth RC; Sigmund CD; Lazartigues E
Circ Res; 2010 Feb; 106(2):373-82. PubMed ID: 19926873
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme 2: a new target for neurogenic hypertension.
Feng Y; Xia H; Santos RA; Speth R; Lazartigues E
Exp Physiol; 2010 May; 95(5):601-6. PubMed ID: 19923158
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice.
Xia H; Feng Y; Obr TD; Hickman PJ; Lazartigues E
Hypertension; 2009 Feb; 53(2):210-6. PubMed ID: 19124678
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-converting enzyme 2 in the brain: properties and future directions.
Xia H; Lazartigues E
J Neurochem; 2008 Dec; 107(6):1482-94. PubMed ID: 19014390
[TBL] [Abstract][Full Text] [Related]
27. Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations.
Camargo SM; Singer D; Makrides V; Huggel K; Pos KM; Wagner CA; Kuba K; Danilczyk U; Skovby F; Kleta R; Penninger JM; Verrey F
Gastroenterology; 2009 Mar; 136(3):872-82. PubMed ID: 19185582
[TBL] [Abstract][Full Text] [Related]
28. Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.
Patel VB; Zhong JC; Grant MB; Oudit GY
Circ Res; 2016 Apr; 118(8):1313-26. PubMed ID: 27081112
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 disease and autoimmune disorders: A mutual pathway.
Al-Beltagi M; Saeed NK; Bediwy AS
World J Methodol; 2022 Jul; 12(4):200-223. PubMed ID: 36159097
[TBL] [Abstract][Full Text] [Related]
30. Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells.
Kapczynski DR; Sweeney R; Spackman E; Pantin-Jackwood M; Suarez DL
Virology; 2022 Apr; 569():1-12. PubMed ID: 35217403
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease.
Cremer S; Pilgram L; Berkowitsch A; Stecher M; Rieg S; Shumliakivska M; Bojkova D; Wagner JUG; Aslan GS; Spinner C; Luxán G; Hanses F; Dolff S; Piepel C; Ruppert C; Guenther A; Rüthrich MM; Vehreschild JJ; Wille K; Haselberger M; Heuzeroth H; Hansen A; Eschenhagen T; Cinatl J; Ciesek S; Dimmeler S; Borgmann S; Zeiher A;
PLoS One; 2021; 16(10):e0258684. PubMed ID: 34673795
[TBL] [Abstract][Full Text] [Related]
32. Possible repair mechanisms of renin-angiotensin system inhibitors, matrix metalloproteinase-9 inhibitors and protein hormones on methamphetamine-induced neurotoxicity.
Zhao W; Zhao YL; Liu M; Liu L; Wang Y
Mol Biol Rep; 2021 Nov; 48(11):7509-7516. PubMed ID: 34623593
[TBL] [Abstract][Full Text] [Related]
33. Renin-angiotensin system blockade in the COVID-19 pandemic.
Cohen JB; South AM; Shaltout HA; Sinclair MR; Sparks MA
Clin Kidney J; 2021 Mar; 14(Suppl 1):i48-i59. PubMed ID: 33796285
[TBL] [Abstract][Full Text] [Related]
34. Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2.
Salamanna F; Maglio M; Landini MP; Fini M
Front Med (Lausanne); 2020; 7():594495. PubMed ID: 33344479
[TBL] [Abstract][Full Text] [Related]
35. Neurological manifestations of severe acute respiratory syndrome coronavirus 2-a controversy 'gone viral'.
Förster M; Weyers V; Küry P; Barnett M; Hartung HP; Kremer D
Brain Commun; 2020; 2(2):fcaa149. PubMed ID: 33210085
[TBL] [Abstract][Full Text] [Related]
36. SAMHD1 as the Potential Link Between SARS-CoV-2 Infection and Neurological Complications.
Khan A; Sergi C
Front Neurol; 2020; 11():562913. PubMed ID: 33101175
[TBL] [Abstract][Full Text] [Related]
37. Brain angiotensin converting enzyme-2 in central cardiovascular regulation.
Mohammed M; Berdasco C; Lazartigues E
Clin Sci (Lond); 2020 Oct; 134(19):2535-2547. PubMed ID: 33016313
[TBL] [Abstract][Full Text] [Related]
38. A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View.
Soltani Zangbar H; Gorji A; Ghadiri T
Mol Neurobiol; 2021 Feb; 58(2):536-549. PubMed ID: 32981023
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of Central ACE2 (Angiotensin-Converting Enzyme 2) Attenuates the Pressor Response to Chronic Central Infusion of Ang II (Angiotensin II): A Potential Role for Nrf2 (Nuclear Factor [Erythroid-Derived 2]-Like 2).
Ma A; Gao L; Wafi AM; Yu L; Rudebush T; Zhou W; Zucker IH
Hypertension; 2020 Nov; 76(5):1514-1525. PubMed ID: 32895018
[TBL] [Abstract][Full Text] [Related]
40. The Actin Bundling Protein Fascin-1 as an ACE2-Accessory Protein.
Ogunlade B; Guidry JJ; Mukerjee S; Sriramula S; Lazartigues E; Filipeanu CM
Cell Mol Neurobiol; 2022 Jan; 42(1):255-263. PubMed ID: 32865675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
